Streetbeat News

Revenues

LEGN

Analyst ratings for Legend Biotech (NASDAQ:LEGN) show a diverse range of opinions, with recent updates indicating a shift towards more bullish sentiments. The average 12-month price target for LEGN has been raised to $84.25, marking an 8.01% increase from the previous target of $78.00. Legend Biotech, a clinical-stage biopharmaceutical company, has shown significant revenue growth of 187.57% as of December 31, 2023, outperforming peers in the Health Care sector. However, the company faces challenges with a net margin of -182.24% and below-average ROE and ROA, indicating potential profitability and asset utilization issues.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 2:01 pm

HWC

In the last three months, 6 analysts have provided diverse ratings on Hancock Whitney (NASDAQ:HWC), with recent assessments showing a shift towards a more cautious outlook. The average 12-month price target for HWC has been adjusted to $50.5, slightly lower than the previous $51.00, reflecting a downward trend in expectations. Analysts from firms including Piper Sandler, Truist Securities, Jefferies, and DA Davidson have updated their ratings and price targets, indicating a nuanced view on the company's future performance. Hancock Whitney's financial health shows challenges in revenue growth, net margin, ROE, and ROA, falling below industry averages, although its debt management appears relatively healthy.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 2:01 pm

BNTX

BioNTech (NASDAQ:BNTX) received mixed ratings from 11 analysts, with a shift towards bullish sentiment in the last 30 days. The average 12-month price target was raised to $130.82, indicating a positive outlook. Analysts adjusted their ratings and price targets, reflecting recent developments and performance. Despite the optimistic analyst ratings, BioNTech faces economic challenges, including a significant revenue decline and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 2:00 pm

ASML

FXI

ASML executives have stated that China continues to account for approximately 20% of the company's order backlog, according to Reuters. This indicates the significant role China plays in ASML's business operations and future revenue expectations.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:00 pm

TWLO

Analyst ratings for Twilio (NYSE:TWLO) show varied sentiments, with recent evaluations and 12-month price targets indicating a slight increase in the average target to $70.12. The analysis includes actions taken by analysts from firms like Oppenheimer, JMP Securities, and Goldman Sachs, reflecting adjustments in ratings and price targets. Twilio's financial performance is highlighted, showing a revenue growth rate of 5.01% and challenges in net margin and profitability, despite a strong market capitalization and efficient asset management.

Portfolio Pulse from Benzinga Insights

April 17, 2024 | 2:00 pm

ASML

FXI

ASML executives have reported strong demand for their equipment from Chinese customers and see no current obstacles to continuing servicing equipment in China, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 2:00 pm

CISS

C3is (CISS) shares are trading higher as traders share a post by meme stock trader Zack Morris mentioning the stock. The company, operating in the oil and shipping sector, has a low float and short interest, with significant cash per share and total cash. It has been profitable with a high profit margin and a substantial increase in total assets. C3is announced an agreement to acquire a Handysize Bulk Carrier, adding to its fleet, with no bank debt and a strong cash position to fund further acquisitions.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:42 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) was featured on the front page of Guizhou Daily, highlighting its achievements in lithium-ion battery anode materials research and production. The report emphasized the company's technological innovation, substantial economic value from patents exceeding $14 million, and its status as one of China's top fifteen anode material suppliers. Sunrise's commitment to developing core patents with market potential and social benefits was also noted.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:28 pm

X

President Joe Biden plans to announce a 25% tariff on specific Chinese steel and aluminum imports during a visit to Pittsburgh, aiming to strengthen the domestic steel sector and counteract China's unfair trade practices. The tariffs, affecting $1.7 billion worth of imports, are part of broader efforts to protect American manufacturing jobs and address industrial concerns. The proposal also includes a review of China's shipbuilding practices and collaboration with Mexico to prevent indirect Chinese steel imports. Economist Ronnie Walker from Goldman Sachs warns that the tariffs could lead to higher consumer prices and have a modestly negative impact on GDP.

Portfolio Pulse from Piero Cingari

April 17, 2024 | 1:22 pm

INTZ

Intrusion Inc.'s partner, iOne, has won a bid approximately worth $25 million for a project with the Commission on Elections. This win signifies a substantial contract for iOne and indirectly benefits Intrusion Inc. (INTZ), showcasing the strength and potential growth of their partnerships and market presence.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 1:20 pm